Yunji’s H2 Revenue Falls 13.7% to RMB158.7M with Net Loss Narrowed 71.7%
Yunji's H2 2025 revenue dropped 13.7% to RMB158.7 million (US$22.7 million) as it scaled back marketplace business, while repeat purchase rate held at 69.7%. Net loss narrowed 71.7% to RMB32.6 million from RMB115.1 million, driven by 43.8% lower operating expenses and disciplined cost management.
1. Revenue and Repeat Purchase Performance
In the second half of 2025, Yunji generated total revenues of RMB158.7 million (US$22.7 million), down from RMB183.8 million a year earlier as the company strategically scaled back its marketplace segment. Despite the contraction, the 12-month repeat purchase rate remained robust at 69.7%, underscoring strong member engagement with premium and organic health products.
2. Profitability and Cost Management
Yunji narrowed its net loss by 71.7%, reporting a loss of RMB32.6 million versus RMB115.1 million in H2 2024. This improvement stemmed from a 43.8% reduction in total operating expenses—driven by a 60.2% cut in fulfillment costs, a 35.5% drop in technology expenses and a 65.5% decrease in general and administrative outlays.
3. Strategic Transformation and Outlook
Management emphasized a shift toward a private label–led model focused on organic health and wellness offerings, aligning with national health initiatives. In 2026, Yunji plans to accelerate health private label development, optimize multi-channel customer acquisition and pursue profitability through resource allocation and enhanced operational efficiency.